<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01091480</url>
  </required_header>
  <id_info>
    <org_study_id>09273</org_study_id>
    <nct_id>NCT01091480</nct_id>
  </id_info>
  <brief_title>French Hypertrophic Cardiomyopathy Observatory</brief_title>
  <acronym>REMY</acronym>
  <official_title>French Hypertrophic Cardiomyopathy Observatory</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>French Cardiology Society</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>French Cardiology Society</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypertrophic cardiomyopathy (Hypertrophic CardioMyopathy=HCM) remains a poorly understood
      disease with an assumption insufficiently codified. There is no data available in France on
      the profile of patients, diagnostic methods and assessment and therapeutic use.

      The purpose of this study is to establish a monitoring of patients with HCM (sarcomere of
      origin or not) in France (diagnosis, treatment)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This both retrospective and prospective study is proposed to cardiology services 50 hospitals
      in France. A cardiologist referral is designated for each facility.

      The following data will be collected by the physician during the initial hospitalization

        -  Demographics

        -  Geographic origin of patient

        -  Clinical data: criteria for inclusion and non-inclusion data HCM general, Doppler
           ultrasound, personal history, family history

        -  Reviews made: non-organic, biological

        -  Family Survey,

        -  Treatments: Medical, Electrical, invasive

        -  Data from hospital

      The follow-up to 18 months, 3 years and 5 years will be conducted by
      clinical-research-technicians of the French Society of Cardiology, an application will be
      made to municipalities of birth and mail a letter to physicians and patients.

      The following data will be collected:

        -  Vital status

        -  Data from hospital

        -  Reviews made: non-organic, biological

        -  Treatments: Medical, Electrical, invasive
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Anticipated">December 2028</completion_date>
  <primary_completion_date type="Anticipated">December 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Event-free survival</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diagnostic methods</measure>
    <time_frame>0 day</time_frame>
    <description>Define the profile of patients with HCM in France, diagnostic methods, evaluation (diagnostic investigation and family) and therapeutic. Who are the patients CMH France? (rules discovery, clinical presentation) and how are assumed the HCM in France? (examinations, hospitalizations, treatments, procedures for the family survey).</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Hypertrophic Cardiomyopathy</condition>
  <arm_group>
    <arm_group_label>Patients with HCM</arm_group_label>
    <description>Patients ≥ 15 years with HCM(sarcomere of origin or not) defined by an ultrasound thickness of the left ventricle ≥ 13 mm if familial or ≥ 15 mm if sporadic</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Systematic search for predisposition genes and Fabry disease in patients with hypertrophic
      cardiomyopathy (GE-REMY) with blood sampling at baseline or during a consultation normally
      scheduled as part of the management of this pathology
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients ≥ 15 years old with HCM (sarcomere of origin or not) defined by an ultrasound
        thickness of the left ventricle ≥ 13 mm if familial or ≥ 15 mm if sporadic
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥ 15 years old

          -  Patient with HCM defined by an ultrasound thickness of the left ventricle ≥ 13 mm if
             familial or ≥ 15 mm if sporadic

        Exclusion Criteria:

          -  Expressed refusal to participate in the study

          -  Significant aortic stenosis (&lt;1 cm ²)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Albert Hagege</last_name>
    <phone>33(0)156092897</phone>
    <email>albert.hagege@egp.ap-hop-paris.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>European Georges Pompidou Hospital</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Albert Hagege</last_name>
      <phone>33(0)156093683</phone>
      <email>albert.hagege@egp.ap-hop-paris.fr</email>
    </contact>
    <contact_backup>
      <last_name>Geneviève Mulak</last_name>
      <phone>33(0)143223333</phone>
      <email>secretariat.registre@sfcardio.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Albert Hagege</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 8, 2010</study_first_submitted>
  <study_first_submitted_qc>March 23, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 24, 2010</study_first_posted>
  <last_update_submitted>November 21, 2017</last_update_submitted>
  <last_update_submitted_qc>November 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>French Cardiology Society</investigator_affiliation>
    <investigator_full_name>Hagege Albert</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Hypertrophic cardiomyopathy</keyword>
  <keyword>Observatory</keyword>
  <keyword>LVH</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiomyopathies</mesh_term>
    <mesh_term>Hypertrophy</mesh_term>
    <mesh_term>Cardiomyopathy, Hypertrophic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

